At a glance
- Originator Unknown
- Developer Nonindustrial source; Unknown
- Class Analgesics; Antihyperglycaemics
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic neuropathies; Neuropathic pain
Most Recent Events
- 30 Jan 2004 Discontinued - Preclinical for Neuropathic pain in United Kingdom (unspecified route)
- 30 Jan 2004 Discontinued for Diabetic neuropathies (unspecified route)
- 15 Sep 1999 No-Development-Reported for Neuropathic pain in United Kingdom (Unknown route)